BEONE MEDICINES LTD. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
BEONE MEDICINES LTD. (ONC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $10.44 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-02-26
- BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $10.44, a 57.70% increase from fiscal 2024.
- BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $6.62, a 18.67% decline from fiscal 2023.
- BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $8.14, a 27.19% increase from fiscal 2022.
- BEONE MEDICINES LTD. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $6.40, a 48.39% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2025-12-31 | $10.44 10-K · filed 2026-02-26 |
| 2024-12-31 | $6.62 10-K · filed 2025-02-27 |
| 2023-12-31 | $8.14 10-K · filed 2025-02-27 |
| 2022-12-31 | $6.40 10-K · filed 2025-02-27 |
| 2021-12-31 | $12.40 10-K · filed 2024-02-26 |
| 2020-12-31 | $7.15 10-K · filed 2023-02-27 |
| 2019-12-31 | $5.06 10-K · filed 2022-02-28 |